The Effect of Virtual Reality on Postoperative Pain and Anxiety in Cardiac Surgery.
Launched by ACADEMISCH MEDISCH CENTRUM - UNIVERSITEIT VAN AMSTERDAM (AMC-UVA) · Aug 14, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether using virtual reality (VR) can help reduce pain and anxiety in patients who have just undergone heart surgery, specifically a procedure called coronary artery bypass grafting (CABG). In this study, some participants will experience a 20-minute VR session on the first three days after their surgery, while others will receive standard care without VR. The goal is to see if the VR experience can make their recovery more comfortable.
To be eligible for this trial, participants must be at least 18 years old and undergoing CABG surgery. However, people with certain health issues, such as severe hearing or vision problems, psychiatric conditions, or those who are claustrophobic, won’t be able to join. If you or a loved one is considering participating, you can expect to engage in a short VR experience during the recovery period, which may help ease discomfort and anxiety after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18 years or older with written informed consent
- • Patients undergoing surgical CABG
- Exclusion Criteria:
- • Major comorbidities besides coronary artery disease
- • Complicated surgical procedure
- • Hearing and/or visual impairments
- • Psychiatric impairments
- • Complaints of vomiting and nausea
- • History of epilepsy
- • Claustrophobia
- • Facial wounds and skin defects at site of application
- • Patients placed in clinical isolation
- • Readmission to the intensive care unit
About Academisch Medisch Centrum Universiteit Van Amsterdam (Amc Uva)
The Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) is a leading academic medical center in the Netherlands, dedicated to advancing healthcare through innovative research, education, and patient care. Affiliated with the University of Amsterdam, AMC-UvA integrates clinical practice with cutting-edge biomedical research, fostering a multidisciplinary approach to medical challenges. The institution actively engages in clinical trials to enhance treatment options and improve patient outcomes, while promoting collaboration among healthcare professionals, researchers, and academic institutions globally. With a commitment to excellence and a focus on translational medicine, AMC-UvA plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amsterdam, Noord Holland, Netherlands
Patients applied
Trial Officials
Jolanda Kluin, MD, PhD
Principal Investigator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported